MDT monthly performance report
Monthly MDT research: returns, drawdown, relative strength, seasonality, and key stats.
MDT monthly report
—
Key takeaways
- Medtronic (MDT) closed August 2026 at $85.99, up 0.70% for the month and −4.10% over the trailing 12 months.
- Year-to-date, MDT is −10.48%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −4.65% versus its 200-day moving average ($90.19), a cautious technical signal.
- Over the past three years, MDT has underperformed the S&P 500 by −69.97%, with a relative strength index reading of 59.4.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Medtronic ended August 2026 at $85.99, posting a monthly return of +0.70%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −2.34%.
The current quarter stands at +9.27% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −4.65% versus the 200-day moving average ($90.19).
Year-to-date, MDT is −10.48% against SPY +12.89%, a gap of −23.37%. The stock is currently −19.13% below its 52-week high, with maximum 3-year drawdown at −30.00%.
| Period | MDT | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.24% | −0.20% | −0.04% |
| 1 Week | −1.02% | +3.90% | −4.93% |
| 1 Month | +0.70% | +3.05% | −2.34% |
| 3 Months | +6.20% | +7.11% | −0.91% |
| 6 Months |